Edition:
United Kingdom

KPC Pharmaceuticals Inc (600422.SS)

600422.SS on Shanghai Stock Exchange

8.93CNY
23 Feb 2018
Change (% chg)

¥0.81 (+9.98%)
Prev Close
¥8.12
Open
¥8.93
Day's High
¥8.93
Day's Low
¥8.88
Volume
11,202,576
Avg. Vol
5,716,275
52-wk High
¥13.35
52-wk Low
¥7.77

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -- December 24 Feb 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 1 1 1 1
(2) OUTPERFORM 0 0 0 0
(3) HOLD 1 1 1 1
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.00 2.00 2.00 2.00

Consensus Estimates Analysis

Sales and Profit Figures in China Yuan Renminbi (CNY)
Earnings and Dividend Figures in China Yuan Renminbi (CNY)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Year Ending Dec-18 1 6,535.00 6,535.00 6,535.00 8,423.62
Earnings (per share)
Year Ending Dec-18 1 0.66 0.66 0.66 1.05

Historical Surprises

Sales and Profit Figures in China Yuan Renminbi (CNY)
Earnings and Dividend Figures in China Yuan Renminbi (CNY)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Jul-11 701.30 727.83 26.53 3.78
Quarter Ending Apr-11 569.05 629.94 60.89 10.70
Quarter Ending Jan-11 505.74 579.38 73.64 14.56
Quarter Ending Oct-10 636.55 496.85 139.70 21.95
Earnings (per share)
Quarter Ending Jul-14 0.14 0.13 0.02 10.34
Quarter Ending Apr-14 0.12 0.08 0.04 32.50
Quarter Ending Jan-14 0.15 0.14 0.01 8.00
Quarter Ending Jul-13 0.12 0.12 0.01 7.20
Quarter Ending Apr-13 0.10 0.07 0.04 34.29

Consensus Estimates Trend

Sales and Profit Figures in China Yuan Renminbi (CNY)
Earnings and Dividend Figures in China Yuan Renminbi (CNY)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Year Ending Dec-18 6,535.00 6,254.00 6,254.00 6,254.00 8,423.62
Earnings (per share)
Year Ending Dec-18 0.66 0.56 0.56 0.56 1.05

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Year Ending Dec-18 0 0 0 0
Earnings
Year Ending Dec-18 0 0 0 0